Stelera is a newer injectable drug that is approved to help treat psoriasis. Psoriasis is another autoimmune condition that I have. It causes annoying scales on my legs and elbows. It is a minor annoyance and much much less demanding than T1.
From what I can tell Stelera works by reducing the body’s immune response to cause psoriasis (http://www.stelarainfo.com/pdf/PrescribingInformation.pdf). One precaution statement for the drug even indicate, “You should not receive the BCG vaccine during
the one year before taking STELARA® or one year after
you stop taking STELARA.”
Could this drug be similar the Dr. Faustman’s BCG Type 1 research and lead to an increase in my residual beta cell function? (If I have any). Could taking this drug lead to beter control of my T1 through increased endogenous insulin production?
My psoriasis is classified as moderate to severe, but it is a minor issue for me. If I were to take this drug it would be nice to not have noticable psoriasis, but I would be more interested on its impact on my T1. Is this too unethical? Let me know what you think.